Antisense Pharma GmbH

https://www.antisense-pharma.com

Antisense Pharma is a pioneer in the development of antisense drugs. Discovered with the help of modern platform technology, the drugs effectively prevent disease-associated proteins to originate. This allows to tackle fatal diseases like cancer at their roots - fighting them causally rather than symptomatically.

The product pipeline comprises agents against malignant brain tumors, colorectal carcinoma, pancreatic carcinoma and malignant melanoma as well as other forms of tumors in various stages of clinical and pre-clinical development. Antisense Pharma has been awarded the Bavarian Innovation Prize as well as the German Founders Award. In addition to MIG-Fonds and along with private investors other venture capital companies like Global Chance Fund, Global Asset Fund, S-Refit, TechnologiebeteiligungsGesellschaft mbH and the Techonologie Beteiligunsgfonds GmbH & Co. KG. are actively involved in Antisense Pharma. *

	Start	1998-01-01 established
	End	2013-09-30 renamed
	Group	Isarna Therapeutics GmbH
	Today	Isarna Therapeutics GmbH
	Successor	Isarna Therapeutics GmbH
	Industry	antisense drug
	Industry 2	cancer drug
	Person	Calais, Philippe (Antisense Pharma 201205– Managing Director CEO before Roche + ICI et al)
	Person 2	Heinrichs, Hubert (Antisense Pharma 201012 Managing Director)

	Region	Regensburg
	Country	Germany
	Street	9 Josef-Engert-Str.
	City	93053 Regensburg
	Tel	+49-941-9201-300
		Address record changed: 2020-12-02

Basic data	Employees	C: 51 to 100 (2008-10-01)

		* Document for »About Section«:

		Record changed: 2025-03-16

Picture EBD Group ChinaBio Partnering Forum 2025 Shanghai 650x200px

More documents for Isarna Therapeutics GmbH

[1] Isarna Therapeutics GmbH. (9/30/21). "Press Release: Isarna Therapeutics Appoints Claus Schalper as CEO". Munich....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)